GW Henssler & Associates Ltd. Reduces Stake in The Allstate Co.

GW Henssler & Associates Ltd. has reduced its investment in The Allstate Co. (NYSE:ALL) by 1.4% in the fourth quarter, according to its latest filing with the SEC. The firm now holds 185,223 shares of Allstate after selling 2,587 shares during this period. Notably, Allstate constitutes 2.1% of GW Henssler & Associates Ltd.’s total holdings, making it the eighth largest investment in its portfolio. As per the recent SEC filing, their stake in Allstate is valued at approximately $35.13 million.

Institutional Investors Adjust Holdings

In addition to GW Henssler, other institutional investors and hedge funds have also modified their positions in Allstate. For instance, SPC Financial Inc. increased its stake by 3.6% in the third quarter, now owning 1,564 shares valued at $297,000 after adding 54 shares. Similarly, Lake Street Advisors Group LLC raised its investment by 1.8%, now holding 3,129 shares worth $596,000. Chicago Partners Investment Group LLC also increased its holdings by 1.3%, holding 4,630 shares valued at $893,000 after purchasing 59 more. Furthermore, Carmichael Hill & Associates Inc. grew its stake by 15.0%, ending up with 460 shares worth $87,000. Lastly, Apella Capital LLC elevated its investment by 1.9% in the fourth quarter, owning 3,231 shares valued at $623,000 after acquiring 60 additional shares. Overall, institutional investors now own about 76.47% of Allstate's stock.

Analysts' Observations on Allstate

Several research firms have recently shared their outlook on Allstate. Goldman Sachs Group raised its price target for Allstate from $209 to $230 and assigned a “buy” rating in a report dated November 15th. Evercore ISI upgraded the rating from “in-line” to “outperform” on January 8th. Bank of America lifted its price target from $216 to $233, also assigning a “buy” rating on October 18th. Likewise, Morgan Stanley raised its price objective from $220 to $228 while giving an “overweight” rating on November 7th. JPMorgan Chase & Co. adjusted their target price from $205 to $207 and marked the stock as “overweight” on October 10th. One analyst issued a sell rating, one provided a hold rating, and a majority of fourteen analysts gave a buy rating. As of now, the consensus rating for Allstate is classified as a "Moderate Buy" with an average price target of $218.13.

Allstate's Stock Performance

Trading for Allstate began at $192.60 on a recent Monday. Over the past twelve months, the stock has seen its lowest point at $153.42 and its highest at $209.88. Currently, the stock's 50-day and 200-day moving averages stand at $193.92 and $188.46, respectively. The company holds a market cap of $51 billion, a price-to-earnings ratio of 12.47, and a PEG ratio of 1.45, coupled with a beta of 0.52.

Dividend Announcement by Allstate

Additionally, Allstate has announced its quarterly dividend, which was distributed on January 2nd. Shareholders who recorded their holdings by November 29th received a dividend of $0.92 per share, resulting in an annualized dividend of $3.68, reflecting a yield of 1.91%. The company's payout ratio is currently at 23.83%.

Overview of The Allstate Corporation

The Allstate Corporation offers a range of insurance products, including property, casualty, and additional services in the United States and Canada. The company operates through five segments: Allstate Protection, Protection Services, Allstate Health and Benefits, Run-off Property-Liability, and Corporate and Other.

Investment, Stake, Insurance